Phase I Clinical and Pharmacologic Study of

Departments of Pediatric Hematology/Oncology, State University of. New York Upstate Medical University, .... Downloaded from ..... Neuro-Oncology, 4: ...

0 downloads 0 Views 152KB Size

Recommend Documents

Apr 1, 2005 - plain redtop tubes and allowed to clot at room temperature. The ... solution was added to the wells and color developed in proportion to.

gene ablates tumorigenesis in mouse models that faithfully mimic the human disease .... exposed to 200 nmol/L BEZ235 for 24 hours relative to con- trol cells.

Jun 1, 2005 - Nancy Harold,2,3,5 Suzanne Fioravanti,2,3,5 Barbara Schuler,2,3,5 Brian P. Monahan,6. M.Wasif Saif ...... TATA-less bidirectional human thymidylate synthase promoter. ... nomics: road to anticancer therapeutics nirvana? On-.

absolute neutrophil count or platelet count were used to .... which would allow the completion of preliminary ...... Ettinger DS, Forastiere AA, Hurowitz LA. ct al.

followed by Cisplatinum and 5-Fluorouracil in Patients with. Advanced Solid Tumors. Kapil N. Bhalla,1 Gondi N. Kumar,. U. Kristina Walle, Ana Maria Ibrado,.

most frequent grade 3 to 4 toxicity was myelosuppression. .... Dex/Thal. 16. 89. Bortezomib. 16. 89. Melphalan. 9. 50. Abbreviations: CLL, chronic lymphocytic leukemia; MM, ... dem mass spectrometry assay with a lower limit of quantification of 0.5 n

Sep 15, 2006 - metastases in multiple solid tumors, including bladder, breast, esophagus, oral .... Australia) in glass vials containing 400 mg sterile lyophilized powder. .... 88 dose, day 28, and, for part 1 of the study only, days 5 and 19. Blood

Apr 18, 2017 - checkpoint interruption with the Chk1/Chk2 inhibitor. AZD 7762 (35). In the present study, only 2 of 10 (20%) patients with a complex karyotype ...

Mar 15, 2008 - cycle of therapy was 805/ul and the median platelet nadir was 48,000/ul. Other toxic .... This was achieved using a Waters model 510 pump and ...

was 6.9 /¿Mwith little interpatient variability seen. ... Phase I study of MP administered as a prolonged i.v. infusion. ... Three patients were treated at 2 different.

Val and 5-methylbenzoic acid form the lateral chain. The cycled region ...... (M)/prednisone (P) in men with androgen independent prostate cancer. J Clin Oncol ...

(/')determined the human pharmacokinetics of the drug on a. 6-h infusion ..... dexamethasone, and/or aminophylline were required to treat the reactions.

POH was formulated in soft gelatin capsules con- .... Drug Formulation. ... phase I design. .... No significant problems with myelosuppression were seen. Grade 1 ...

Stevens, S. J. Lee, D. A. Lowenthal, I. Haines, T. D. Walsh,. L. Baltzer ..... potential antitumor agents: a selective screening study. Cancer Treat. Rep.,. 62:45-74 ...

Mar 15, 2008 - nary function defined as a carbon monoxide diffusion capacity of at least 80% of predicted and a ... UV detection was accom plished using a ...

Antisense Oligonucleotide ISIS 3521 Administered in Combination with 5-Fluorouracil and Leucovorin in Patients with. Advanced Cancer1. Sridhar Mani,2 ...

Phase I and Clinical Pharmacology Study of Intravenous Flavone Acetic Acid. (NSC347512)1 .... tration was achieved by evaporation under nitrogen. A standard ...

Jul 15, 1995 - Phase I Clinical and Pharmacological Study of Suppression of Human Antimouse. Antibody ... V. V., D. B., H. W., G. H.¡,Laboratory Medicine ¡H.F.], and Clinical Immunology and Biological Therapy [J. L M.],. The University of ....

cis-Diamminedichloroplatinum(II) in Patients with Advanced Cancer1. Richard L. ... Received 12/2/85; revised 3/14/86; accepted 4/28/86. The costs of .... ately centrifuged, and the plasma was decanted and frozen at —20°C until the time of ...

staurosporine family of agents, which have two indole nitrogens linked to a carbohydrate residue. Representatives from both of these subgroups have been the ...

to the antifolate drugs trimetrexate, metoprine, homofolate, and CB3717 in human lymphoma and osteosarcoma cells resistant to methotrexate. Cancer. Res.

ables was determined by the Pearson correlation coefficient. .... the plasma levels to increase with higher doses (Pearson corre- ..... Vss (observed) (liters/m2).

infusion solutions are compatible with PVC i.v. infusion bags and are chemically stable ... two cycles of treatment. Disease assessments by any tech- ...... Click on "Request Permissions" which will take you to the Copyright Clearance Center's.

anemia, and brief transaminasemia. One patient who received antibody alone had an apparent acute immune complex-mediated reaction. Ten of. 11 patients ...